CANNRA Advocates Comprehensive CBD Regulation and Enhanced FDA Authority

CANNRA Advocates Comprehensive CBD Regulation and Enhanced FDA Authority

In response to inquiries from key House and Senate committees, the Cannabis Regulators Association (CANNRA) has underscored the importance of creating a comprehensive regulatory framework for hemp-based cannabinoids, including emerging compounds like delta-8 THC. CANNRA’s expert input emphasizes the need for enhanced regulatory authority for an agency like the Food and Drug Administration (FDA). This strategic move aims to ensure consumer safety, address regulatory gaps, and provide clear guidelines for the evolving cannabis market.

Addressing the Scope and Complexity

CANNRA’s message to the House Energy & Commerce Committee and Senate Health, Education, Labor, and Pensions (HELP) Committee resonates with a call for comprehensive action. While the spotlight has often focused on CBD, the federal legalization of hemp under the 2018 Farm Bill extended beyond just CBD. Derivatives like delta-8 THC and THC-O-acetate were also included, leading to complex regulatory challenges. CANNRA notes that this broad legalization effectively brought marijuana under the umbrella of “hemp.”

Holistic Regulatory Approach

CANNRA’s recommendations advocate for an all-encompassing regulatory approach that goes beyond CBD. The organization points out that hemp-derived products have various modes of consumption, and many extend beyond the scope of traditional state-regulated “marijuana” markets. This comprehensive framework aims to ensure consumer safety, public health, and regulatory clarity for both existing and emerging hemp-based cannabinoids.

Empowering the FDA

The call for enhanced regulatory authority for the FDA reflects a consensus that the agency is best positioned to navigate the complexities of this evolving market. CANNRA acknowledges that existing regulatory pathways lack the necessary scope and oversight for various hemp-derived products, including those that are aerosolized, inhaled, or combusted. The organization suggests that the FDA needs specific authorities and defined timelines to establish robust regulations that safeguard consumers and promote public health.

Collaborative and Effective Regulation

CANNRA’s submission also underscores the importance of collaboration between federal and state authorities. While federal regulations are essential, states should retain the ability to enact regulations that exceed federal minimums, ensuring tailored measures that protect their communities and consumers. This collaborative approach seeks to harmonize efforts for effective and informed regulation.

As the congressional committees explore CBD regulation, responses from entities like CANNRA highlight the complexity of the cannabis landscape. The organization’s insights emphasize the need for a proactive approach that addresses emerging cannabinoids, acknowledges the limitations of existing regulatory frameworks, and empowers regulatory agencies to promote safety and responsible consumption.

Don’t miss out on the opportunity to be in the know about the evolving world of cannabis. Subscribe to NECANN today.